XML 20 R4.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Operations - USD ($)
shares in Millions, $ in Millions
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Net sales      
Net sales $ 3,460.7 $ 3,905.2 $ 3,902.3
Cost of sales      
Cost of sales 2,703.4 2,861.8 2,867.3
Gross profit 757.3 1,043.4 1,035.0
Selling and administrative expense 741.6 775.6 858.6
Research, development and engineering expense (120.7) (126.3) (133.4)
Impairment of assets 111.8 1.3 7.5
Gain (Loss) on Disposition of Assets (5.1) (3.1) (11.5)
Total operating expense (969.0) (906.3) 1,011.0
Operating profit (loss) (211.7) 137.1 24.0
Other income (expense)      
Interest income 10.0 6.1 6.8
Interest expense (199.2) (195.3) (266.8)
Foreign exchange loss, net (7.8) (2.0) (14.4)
Miscellaneous, net 2.2 3.4 6.8
Gains (Losses) on Restructuring of Debt (32.1) 0.0 (25.9)
Loss before taxes (438.6) (50.7) (269.5)
Income tax expense (benefit) 149.2 27.7 (1.0)
Equity in earnings (loss) of unconsolidated subsidiaries, net 2.2 0.3 0.7
Net loss (585.6) (78.1) (267.8)
Net income (loss) income attributable to noncontrolling interests (4.2) 0.7 1.3
Net loss attributable to Diebold Nixdorf, Incorporated $ (581.4) $ (78.8) $ (269.1)
Weighted-average number of common shares used in basic and diluted earnings (loss) per share (1) 79.0 78.3 77.6
Service [Member]      
Net sales      
Net sales $ 2,098.9 $ 2,303.6 $ 2,364.4
Cost of sales      
Cost of sales 1,480.8 1,577.3 1,666.2
Product [Member]      
Net sales      
Net sales 1,361.8 1,601.6 1,537.9
Cost of sales      
Cost of sales $ 1,222.6 $ 1,284.5 $ 1,201.1